Spindle Cell/Sclerosing Rhabdomyosarcoma With PAX8::PPARG Fusion.
Rakheja D, Park JY, Alhasan M, Uddin N.
Int J Surg Pathol. 2022 Dec;30(8):950-955. doi: 10.1177/10668969221095170. Epub 2022 Apr 24.
Conjunctival Spindle Cell/Sclerosing Rhabdomyosarcoma.
Su YW, Wang LC, Fan NW.
Ophthalmology. 2024 Aug;131(8):926. doi: 10.1016/j.ophtha.2023.09.027. Epub 2023 Oct 24.
Evolving classification of rhabdomyosarcoma.
Agaram NP.
Histopathology. 2022 Jan;80(1):98-108. doi: 10.1111/his.14449.
Challenges in the Diagnosis of Pediatric Spindle Cell/Sclerosing Rhabdomyosarcoma.
Chen S, Rudzinski ER, Arnold MA.
Surg Pathol Clin. 2020 Dec;13(4):729-738. doi: 10.1016/j.path.2020.08.010. Epub 2020 Oct 9.
Spindle Cell/Sclerosing Rhabdomyosarcoma of the Orbit.
Proia AD.
Ophthalmic Plast Reconstr Surg. 2023 Jan-Feb 01;39(1):e17-e20. doi: 10.1097/IOP.0000000000002252. Epub 2022 Jul 13.
[Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
Xu JT, Fu LB, Yao XF, Jia C, Guan XX, Zhang M, He LJ.
Zhonghua Bing Li Xue Za Zhi. 2024 Apr 8;53(4):344-350. doi: 10.3760/cma.j.cn112151-20231024-00294.
Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B, Dodd L, Dharavath B, Dutt A.
Diagn Cytopathol. 2022 Dec;50(12):E367-E372. doi: 10.1002/dc.25032. Epub 2022 Aug 5.
Multifaceted Spindle Cell/Sclerosing Rhabdomyosarcoma With Role of Immunohistochemistry in Avoiding Misdiagnosis: A Multi-Institutional Study of 45 Distinct Tumors.
Jain E, Munjal G, Sharma S, Brar Z, Bhardwaj N, Dewan A, Jain D, Jha S, Lobo A, Malik V, Arora S, Varshney J, Beg A, Sampat NY, Parwani AV, Balzer B, Varma M, Yadav BS, Sharma SK, Singh HP, Gogoi K, Kumar D, Bhandari V, Fulara LM, Kumar A, Singh H, Bhattacharya M, Dixit M, Mohanty SK.
Int J Surg Pathol. 2024 May;32(3):496-506. doi: 10.1177/10668969231188422. Epub 2023 Jul 25.
MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
Agaram NP, LaQuaglia MP, Alaggio R, Zhang L, Fujisawa Y, Ladanyi M, Wexler LH, Antonescu CR.
Mod Pathol. 2019 Jan;32(1):27-36. doi: 10.1038/s41379-018-0120-9. Epub 2018 Sep 4.
Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
Dehner CA, Rudzinski ER, Davis JL.
Hum Pathol. 2024 May;147:72-81. doi: 10.1016/j.humpath.2023.12.004. Epub 2023 Dec 21.
